Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Rocket Pharmaceuticals, Inc.
< Previous
1
2
Next >
Rocket Pharmaceuticals Provides Update on Anticipated Registration Path for RP-A501 in Danon Disease Following End-of-Phase 1 FDA Meeting
December 22, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Presents Positive Clinical Data from Fanconi Anemia, Pyruvate Kinase Deficiency and Severe Leukocyte Adhesion Deficiency-I Programs at the 64th American Society of Hematology (ASH) Annual Meeting
December 12, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Completes Acquisition of Renovacor
December 01, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals to Present at the 5th Annual Evercore ISI HealthCONx Conference
November 21, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Reports Third Quarter 2022 Financial Results and Highlights Recent Progress
November 03, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Announces Presentations Highlighting AAV and Lentiviral Gene Therapies at Upcoming Scientific Congresses
November 03, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Announces Presentations Highlighting Lentiviral Gene Therapies at the 29th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
October 12, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals to Present at the 2022 Cell & Gene Meeting on the Mesa
October 10, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock
October 03, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock
October 03, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial for RP-A501 in Danon Disease at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2022
September 30, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals to Present at Chardan 6th Annual Genetic Medicines Conference
September 27, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals to Present Updated Data from Phase 1 Danon Disease Trial for RP-A501 at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2022
September 16, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals to Present at Morgan Stanley 20th Annual Global Healthcare Conference
September 06, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Reports Second Quarter 2022 Financial Results and Highlights Recent Progress
August 08, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Appoints Mayo Pujols as Chief Technical Officer and Strengthens Manufacturing Capabilities
July 27, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals to Present at William Blair Biotech Focus Conference
July 08, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
May 19, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Presents Positive Clinical Data from Danon Disease, Fanconi Anemia and Pyruvate Kinase Deficiency Programs at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
May 16, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals to Present at UBS Global Healthcare Conference
May 11, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Reports First Quarter 2022 Financial Results and Highlights Recent Progress
May 05, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals to Present at the Bank of America Securities 2022 Global Healthcare Conference
April 27, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals to Present at Upcoming Investor Conferences
March 29, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Appoints Fady Malik, M.D., Ph.D., to Board of Directors
March 14, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Announces Participation in 11th Annual SVB Leerink Global Healthcare Conference
February 10, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference
January 04, 2022
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Presents Positive Clinical Data from Company’s Lentiviral Gene Therapies for Treatment of Fanconi Anemia, LAD-I and PKD at the 63rd American Society of Hematology (ASH) Annual Meeting
December 13, 2021
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Appoints Martin L. Wilson as General Counsel and Chief Compliance Officer
December 08, 2021
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals to Host In-Person Investor and Analyst Event and Webcast on Tuesday, Dec. 14 at 7:30 a.m. ET to Discuss Updated Clinical Data Presented at the 63rd American Society of Hematology (ASH) Annual Meeting
December 07, 2021
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
Rocket Pharmaceuticals Announces Participation in Evercore ISI 4th Annual HEALTHCONx Virtual Conference
November 22, 2021
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Tickers
RCKT
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.